Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells

被引:29
|
作者
Wang, Quan [1 ,2 ]
He, Wei-Yang [1 ]
Zeng, Yi-Zhou [1 ,2 ]
Hossain, Arman [1 ,2 ]
Gou, Xin [1 ]
机构
[1] Chongqing Med Univ, Dept Urol, Affiliated Hosp 1, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Cent Lab, Affiliated Hosp 1, Chongqing 400016, Peoples R China
关键词
Castration-resistant prostate cancer; Docetaxel resistance; Autophagy; Tea polyphenol; STARVATION-INDUCED AUTOPHAGY; SIGNAL-REGULATED KINASE; TEA POLYPHENOLS; GREEN TEA; ACTIVATION; SENSITIVITY; APOPTOSIS; PATHWAY; PREVENTION; EXPRESSION;
D O I
10.1007/s11255-018-1801-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This study investigates the docetaxel-resistant mechanism and explores the effect of tea polyphenols (TP) on autophagy and its related mechanism in human castration-resistant prostate cancer (CRPC) cell lines PC3 and DU145. Immunofluorescence assay and annexin V-FITC/PI double staining flow cytometry were used to analyze the apoptosis and autophagy of PC3 and DU145 cells. The expression of autophagy-related proteins was detected by western bolt. Docetaxel could induce autophagy and apoptosis, together with the expression increase in p-JNK, p-Bcl-2 and Beclin1. The level of autophagy was remarkably decreased, but apoptosis was increased after combining with TP. In addition, the expression of p-mTOR was increased after combining with TP. Docetaxel induces protective autophagy in CRPC cells by JNK pathway activation and then Bcl-2 phosphorylation and Beclin1 dissociation. TP activates mTOR pathway, which ultimately inhibits docetaxel-induced autophagy and improves therapeutic efficacy of docetaxel in CRPC cells.
引用
收藏
页码:675 / 686
页数:12
相关论文
共 50 条
  • [41] Pathways of chemotherapy resistance in castration-resistant prostate cancer
    Mahon, Kate L.
    Henshall, Susan M.
    Sutherland, Robert L.
    Horvath, Lisa G.
    ENDOCRINE-RELATED CANCER, 2011, 18 (04) : R103 - R123
  • [42] Drug resistance in metastatic castration-resistant prostate cancer
    Seruga, Bostjan
    Ocana, Alberto
    Tannock, Ian F.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (01) : 12 - 23
  • [43] Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer
    C Wilson
    P Scullin
    J Worthington
    A Seaton
    P Maxwell
    D O'Rourke
    P G Johnston
    S R McKeown
    R H Wilson
    J M O'Sullivan
    D J J Waugh
    British Journal of Cancer, 2008, 99 : 2054 - 2064
  • [44] Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
    Kreis, Kristine
    Horenkamp-Sonntag, Dirk
    Schneider, Udo
    Zeidler, Jan
    Glaeske, Gerd
    Weissbach, Lothar
    BJU INTERNATIONAL, 2022, 129 (04) : 470 - 479
  • [45] Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience
    Beatrice, Detti
    Davide, Franceschini
    Calogero, Saieva
    Lucia, Di Brina
    Mohammed, Baki
    Icro, Meattini
    Vanessa, Di Cataldo
    Eleonora, Monteleone Pasquetti
    Ilaria, Furfaro
    Anna, Mancuso
    Gabriele, Simontacchi
    Lorenzo, Livi
    CANCER INVESTIGATION, 2014, 32 (09) : 445 - 450
  • [46] Targeting molecular resistance in castration-resistant prostate cancer
    Chandrasekar, Thenappan
    Yang, Joy C.
    Gao, Allen C.
    Evans, Christopher P.
    BMC MEDICINE, 2015, 13
  • [47] Targeting molecular resistance in castration-resistant prostate cancer
    Thenappan Chandrasekar
    Joy C. Yang
    Allen C. Gao
    Christopher P. Evans
    BMC Medicine, 13
  • [48] Is chemical/surgical castration necessary during docetaxel chemotherapy for castration-resistant prostate cancer?
    Watanabe, Masahito
    Kanao, Kent
    Muramatsu, Hiroyuki
    Morinaga, Shingo
    Kajikawa, Keishi
    Kobayashi, Ikuo
    Nishikawa, Genya
    Kato, Yoshiharu
    Nakamura, Kogenta
    Sumitomo, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
    de Leeuw, Renee
    Cao, Qi
    Lam, Hung-Ming
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer
    Heck, Matthias M.
    Thalgott, Mark
    Retz, Margitta
    Wolf, Petra
    Maurer, Tobias
    Nawroth, Roman
    Hatzichristodoulou, Georgios
    Gschwend, Jurgen E.
    Kuebler, Huebert
    BJU INTERNATIONAL, 2012, 110 (11B) : E635 - E640